Tag: disintegrating lansoprazole

FDA, Regulations

Dr. Reddy’s gets FDA nod for orally disintegrating lansoprazole 

February 23, 2021

Via: FiercePharma

Dr. Reddy’s Laboratories has introduced an orally disintegrating formulation of lansoprazole to the U.S. market. The new product is the therapeutic equivalent of the Prevacid SoluTab delayed-release tablets sold by Takeda. Lansoprazole is a proton pump inhibitor, a mechanism of […]